🔎 Trials Near Me

Home › Breast Cancer › NCT06981208

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Patient Eligibility Criteria:

* Scheduled for initial preoperative breast reconstruction consultation following therapeutic or prophylactic mastectomy with a surgeon at Washington University School of Medicine.
* At least 18 years of age.
* Can speak and understand English.

Surgeon Eligibility Criteria:

* Routinely performs breast reconstruction surgery at Washington University School of Medicine.
* At least 18 years of age.
* Can speak and understand English.
* Surgeon must not be a resident or fellow at time of enrollment.

About the study

In this study, patients who are scheduled for breast reconstruction consultation will be randomized into the intervention group (ChatGPT-generated patient education regarding possible reconstruction options) or the control group (usual patient education). All patients will complete a survey following their in-person consultation to assess their experience and overall satisfaction with the consultation process. Additionally, participating surgeons will complete a separate survey to evaluate their consultation experience, satisfaction, and to assess the accuracy and clinical utility of the ChatGPT-generated patient education materials. The surveys are designed to gather information on patient characteristics, organizational health literacy according to Brega et al. Other survey questions have been designed to meet the outcomes of this study and have not been based on previously published surveys.

What is being tested

Sponsor: Washington University School of Medicine · Participants: 410 · Started: Jun 3, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06981208

Locations in the U.S.

MissouriWashington University School of Medicine, St Louis

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.